Infection Control Surveillance Solutions Market Size & Growth Forecast 2027–2036, By Segments (Component, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Infection Control Surveillance Solutions Market size was valued at USD 884.5 million in 2026 and is anticipated to grow at a 12.45% CAGR from 2027 to 2036, crossing USD 2.86 billion by 2036. The industry revenue for 2027 is assessed at USD 977.2 million.
Get more details on this report
Request Free Sample ReportInfection Control Surveillance Solutions Market Intelligence Snapshot
Regional Market Dynamics
- North America held 52.82% share due to widespread healthcare IT adoption, integrated surveillance platforms, infection prevention protocols, and continuous hospital monitoring systems.
- Asia Pacific is projected to grow at 14.67% CAGR driven by healthcare modernization, structured reporting systems, and shift from manual infection tracking to software-based surveillance tools.
Segment Momentum
- Software held a 61.5% share in 2026 because it serves as the operational core for surveillance data capture, infection tracking, alert generation, analytics, and routine reporting across healthcare settings.
- Long Term Care Facilities are the fastest-growing end-use segment as providers expand infection monitoring capabilities to improve surveillance among vulnerable residents and strengthen day-to-day infection control practices.
Market Expansion Drivers
- Rising prevalence of hospital-acquired infections driving adoption of advanced surveillance systems.
- Government infection control initiatives accelerating deployment of healthcare surveillance technologies.
- Increasing hospital digitization improving integration of real-time infection monitoring platforms.
Leading Market Participants
- Prominent players in the infection control surveillance solutions market include Becton, Dickinson and Company (United States), Premier, Inc. (United States), Wolters Kluwer N.V. (Netherlands), Oracle Corporation (United States), Baxter International Inc. (United States), Merative (United States), RLDatix Ltd (United Kingdom), GOJO Industries, Inc. (United States), IQVIA Holdings Inc. (United States), Epic Systems Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 884.5 million
- 2027 Estimated Market Size: USD 977.2 million.
- Projected Market Size: USD 2.86 billion by 2036
- Growth Forecast: 12.45% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Software (Component) | Hospitals (End-use)
- Emerging Opportunity Segment: Services (Component) | Long Term Care Facilities (End-use)
Market Growth Drivers and Industry Trends
Rising prevalence of hospital-acquired infections driving adoption of advanced surveillance systems
The persistent challenge of hospital-acquired infections is increasing demand for stronger monitoring capabilities and will support the infection control surveillance solutions market as healthcare facilities seek to identify infection risks more rapidly. Advanced surveillance systems can help infection control teams collect, organize, and analyze information related to infection incidents, patient populations, and potential transmission patterns. Improved visibility enables healthcare organizations to detect emerging issues earlier, monitor infection-control practices, and coordinate interventions across departments, particularly in complex hospital environments where multiple sources of infection risk must be managed simultaneously.
Government infection control initiatives accelerating deployment of healthcare surveillance technologies
Government-led infection prevention programs and stronger healthcare quality requirements are encouraging investment in surveillance technologies, thereby contributing to the infection control surveillance solutions market. Public health authorities increasingly emphasize systematic monitoring, reporting, and prevention of healthcare-associated infections, prompting healthcare facilities to strengthen their infection control infrastructure. Digital surveillance platforms can facilitate standardized data collection and improve communication between clinical teams and infection prevention personnel, helping institutions align operational practices with evolving infection-control priorities.
Increasing hospital digitization improving integration of real-time infection monitoring platforms
The ongoing digitization of hospital operations is creating a more favorable environment for the infection control surveillance solutions market by enabling infection-related information to be incorporated into broader healthcare information systems. Digital patient records, connected clinical workflows, and interoperable data platforms can provide surveillance tools with timely information for identifying potential infection patterns and monitoring affected patient groups. Real-time access to relevant clinical and operational data can reduce dependence on fragmented manual processes while helping infection control teams respond more efficiently to changing conditions within healthcare facilities.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of hospital-acquired infections driving adoption of advanced surveillance systems | 2.00% | High | North America, Europe | High | Near Term |
| Government infection control initiatives accelerating deployment of healthcare surveillance technologies | 1.70% | High | Asia Pacific, North America | High | Mid Term |
| Increasing hospital digitization improving integration of real-time infection monitoring platforms | 1.40% | Moderate | Europe, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The infection control surveillance solutions market was led by North America, which held a 52.82% share in 2026. The region benefits from well-established healthcare infrastructure, strong emphasis on patient safety, and widespread implementation of digital systems for monitoring healthcare-associated infections. Increasing attention to infection prevention, regulatory compliance, and data-driven clinical decision-making continues to support the deployment of surveillance solutions. The growing integration of healthcare information systems also enables providers to strengthen monitoring capabilities and improve infection control practices.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to emerge as the fastest-growing region as healthcare systems invest in hospital modernization and advanced infection prevention infrastructure. Rising healthcare expenditure, expanding access to medical services, and increasing awareness of healthcare-associated infections are encouraging the adoption of surveillance technologies. The digital transformation of hospitals and greater use of automated data collection and analytics are expected to further strengthen demand across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Data-Driven Infection MonitoringGermany is strengthening infection control surveillance through greater adoption of digital monitoring platforms across healthcare facilities. German hospitals prioritize integrated surveillance systems that improve data accuracy, streamline infection reporting, and support evidence-based infection prevention strategies.
France 🇫🇷
Compliance-Focused SurveillanceFrance is advancing infection control surveillance through digital solutions that improve monitoring consistency and regulatory compliance. French healthcare providers prioritize centralized data management and actionable insights to reinforce infection prevention efforts across hospital networks.
Italy 🇮🇹
Integrated Infection OversightItaly is increasing adoption of infection control surveillance solutions as healthcare providers modernize infection monitoring capabilities. Italian hospitals focus on improving reporting efficiency, coordinating infection prevention activities, and supporting clinical teams with automated surveillance technologies.
Japan 🇯🇵
Clinical Workflow EnhancementJapan is expanding infection control surveillance solutions to improve hospital safety and operational efficiency. Japanese healthcare organizations increasingly integrate surveillance technologies with electronic clinical systems to enable timely intervention and strengthen infection prevention programs.
South Korea 🇰🇷
Real-Time Hospital SurveillanceSouth Korea continues adopting infection control surveillance solutions that support rapid detection of infection trends within healthcare settings. South Korean hospitals emphasize real-time monitoring, automated alerts, and integrated analytics to strengthen patient safety and clinical decision-making.
United States 🇺🇸
Hospital Surveillance OptimizationThe U.S. infection control surveillance solutions market is driven by healthcare facilities seeking automated monitoring and faster identification of healthcare-associated infections. U.S. providers increasingly invest in analytics-enabled platforms that strengthen infection prevention workflows and regulatory reporting efficiency.
Segment Leadership and Growth Trends
Infection Control Surveillance Solutions Market Share (%), by Component, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportComponent Segment Analysis: Software (Largest Segment) vs Services (Fastest-Growing Segment)
The software segment held the largest share of the infection control surveillance solutions market at 61.5% in 2026, driven by the growing need for automated infection monitoring, real-time data analysis, and centralized surveillance across healthcare settings. Software platforms enable healthcare providers to consolidate information from multiple clinical and laboratory sources, identify infection patterns, support timely intervention, and streamline reporting requirements. The increasing focus on reducing healthcare-associated infections and improving operational efficiency continues to strengthen demand for integrated surveillance solutions.
The services segment is expected to be the fastest-growing segment, supported by the increasing complexity of implementing, integrating, and maintaining infection surveillance platforms. Healthcare organizations are increasingly seeking specialized support for system deployment, data management, workflow customization, staff training, and ongoing optimization. The continued expansion of digital health infrastructure and the need to maximize the effectiveness of surveillance technologies are expected to accelerate demand for professional and managed services.
End-use Segment Analysis: Hospitals (Largest Segment) vs Long Term Care Facilities (Fastest-Growing Segment)
Hospitals dominated the end-use segment of the infection control surveillance solutions market with a 76.13% share in 2026, owing to their high patient volumes, complex clinical environments, and significant need for continuous infection monitoring. These facilities require comprehensive surveillance capabilities to track healthcare-associated infections, analyze trends across departments, and support infection prevention teams in making timely decisions. Increasing emphasis on patient safety, regulatory compliance, and data-driven clinical management further supports the widespread adoption of surveillance solutions in hospitals.
Long term care facilities represent the fastest-growing end-use segment, driven by the increasing need for systematic infection prevention and early outbreak detection among vulnerable resident populations. The adoption of digital surveillance tools can help these facilities improve monitoring, coordinate infection-control activities, and respond more effectively to emerging risks. Growing awareness of the importance of structured infection management and the modernization of care delivery systems are expected to support accelerated adoption in this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Component | Software, Services | Software | Services |
| End-use | Hospitals, Long Term Care Facilities, Others | Hospitals | Long Term Care Facilities |
Competitive Landscape and Market Positioning
Leading companies in the infection control surveillance solutions market:
1. Becton Dickinson and Company (United States)
2. Premier Inc. (United States)
3. Wolters Kluwer N.V. (Netherlands)
4. Oracle Corporation (United States)
5. Baxter International Inc. (United States)
6. Merative (United States)
7. RLDatix Ltd (United Kingdom)
8. GOJO Industries Inc. (United States)
9. IQVIA Holdings Inc. (United States)
10. Epic Systems Corporation (United States)
The infection control surveillance solutions market is evolving through increasing adoption of data-driven monitoring systems and AI-supported infection tracking technologies. Healthcare providers are investing in real-time surveillance platforms that improve reporting accuracy, outbreak detection, and regulatory compliance management. Enhanced integration with hospital information systems is additionally strengthening operational efficiency and infection prevention strategies.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (United States) | |||||||
| Premier Inc. (United States) | |||||||
| Wolters Kluwer N.V. (Netherlands) | |||||||
| Oracle Corporation (United States) | |||||||
| Baxter International Inc. (United States) | |||||||
| Merative (United States) | |||||||
| RLDatix Ltd (United Kingdom) | |||||||
| GOJO Industries Inc. (United States) | |||||||
| IQVIA Holdings Inc. (United States) | |||||||
| Epic Systems Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Becton Dickinson and Company | May-25 | Becton Dickinson announced a USD 2.5 billion investment in U.S. manufacturing infrastructure alongside receiving FDA clearance for an integrated antimicrobial-resistance diagnostic. This expansion strengthens the company's production capacity and technical capabilities in the infection control and diagnostics space, positioning it to better meet institutional demand for advanced resistance detection and surveillance tools. |
| Becton Dickinson and Company | May-25 | Becton Dickinson launched the FACSDiscover A8 Cell Analyzer, incorporating spectral, real-time imaging technology for the analysis of over 50 biomarkers. This innovation enhances throughput and precision for infection research, enabling healthcare and laboratory facilities to accelerate data acquisition and improve investigative capabilities in complex infectious disease diagnostics. |
| Wolters Kluwer | Mar-25 | Wolters Kluwer deployed its AI Labs platform, powered by UpToDate, across 100 hospital systems. This initiative integrates generative AI with validated clinical content to support clinical surveillance and decision-making. The rollout represents a strategic effort to scale AI-driven insights within clinical workflows, directly enhancing the surveillance and identification of at-risk patient populations. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Infection Control Surveillance Solutions Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Surveillance Type | Active Surveillance, Passive Surveillance, Syndromic Surveillance, Outbreak Surveillance |
| Infection Type | Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections |
| Automation Level | Manual Surveillance, Semi-Automated Surveillance, Fully Automated Surveillance |
Infection Control Surveillance Solutions Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Healthcare Facility Infection Surveillance Maturity Benchmarking |
|
| Hospital Digital Infection Prevention Roadmap |
|
| Infection Surveillance Procurement and Buying Criteria Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow large is the infection control surveillance solutions market?
What is the anticipated CAGR of the infection control surveillance solutions industry?
How are healthcare providers transforming infection surveillance strategies to improve clinical response?
Why is hospital digitization strengthening demand for infection control surveillance solutions?
Why is Software the leading component in the infection control surveillance solutions market?
What is supporting the rapid growth of Long Term Care Facilities in this market?
Why does North America lead the infection control surveillance solutions market?
What is driving Asia Pacific growth in infection surveillance solutions?
Who holds a significant market share in the infection control surveillance solutions landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization